The Morning Brief

Corner Office Conversation with G.V. Prasad, Co-Chairman and Managing Director Dr Reddy’s Laboratories Ltd

Mar 23, 2026
G.V. Prasad, Co-Chairman and Managing Director of Dr. Reddy’s with 30+ years steering pharma and manufacturing, talks candidly about the company’s past crises and missed bold moves. He discusses India's innovation gap, plans to build biologics and new modalities, the realistic role of AI, funding strategies beyond generics, and a ten-year target to shift a large share of revenue to innovation.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
ANECDOTE

Early Crisis Recovery Using Veteran Anchors

  • G.V. Prasad joined Dr. Reddy's in 1990 to stabilize the company after a co-founder left and many people followed him out.
  • He leaned on veteran anchors in the team to rebuild resilience and restore operations quickly, emphasising the role of committed people.
ANECDOTE

Crises That Forced Quality And Safety Overhaul

  • Prasad recounts crises: an anti-dumping suit, fatal plant safety incidents, and multiple FDA warning letters across sites.
  • Each crisis forced investments in legal defence, safety culture, and remediation that ultimately raised quality and compliance standards.
INSIGHT

Conservative Posture Cost Transformational Deals

  • Prasad admits Dr. Reddy's was not aggressive enough in funding innovation and became cautious after one acquisition mistake.
  • As a result, the company missed game-changing M&A and leaned toward incremental acquisitions instead of transformational bets.
Get the Snipd Podcast app to discover more snips from this episode
Get the app